Showing results (21-30 of 149) with videos related to
Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|November 28, 2025
Long-Read Sequencing Enhances Pharmacogenomic Profiling by Resolving Complex Haplotypes, Novel Star Alleles, and Structural VariantsSumudu Rangika Samarasinghe, Andrea Gaedigk, Jesse J Swen, et al.The Pharmacogenomics Journal|October 19, 2019
Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic reviewFrank Eektimmerman, Jesse J Swen, Moenira B Madhar, et al.Pharmacogenomics|May 17, 2016
Evaluation of clinical implementation of prospective DPYD genotyping in 5-fluorouracil- or capecitabine-treated patientsCarin Atc Lunenburg, Maurice C van Staveren, Hans Gelderblom, et al.Pharmacogenomics|April 28, 2018
SLC04A1, SLC22A2 and SLC28A2 variants not related to methotrexate efficacy or toxicity in rheumatoid arthritis patientsFrank Eektimmerman, Jesse J Swen, Stefan Böhringer, et al.Pharmacogenomics|December 17, 2013
Pharmacogenetics of taste: turning bitter pills sweet?Mariëlle J Nagtegaal, Jesse J Swen, Lidwien M Hanff, et al.Pharmacogenomics|December 3, 2010
Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitusJesse J Swen, Judith A M Wessels, Annemarie Krabben, et al.Frontiers in Pharmacology|August 7, 2024
Pharmacogenetic educational needs and the role of pharmacogenetics in primary care: a focus group study with multiple perspectivesMaaike E Ferwerda, Jessica A Wright, Razan M El Melik, et al.Cancers|December 23, 2023
IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial)Nadia de Gruil, Stefan Böhringer, Stefanie de Groot, et al.Therapeutic Advances in Rare Disease|November 13, 2023
Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogeneticsStephanie Feleus, Maaike van der Lee, Jesse J Swen, et al.Cancer Chemotherapy and Pharmacology|July 13, 2026
Design characteristics of mass balance studies conducted for protein kinase inhibitorsBenthe Riechelman, Ramon Bolks, Thijs H Oude Munnink, et al.Pageof 15